CMTA and Applied Therapeutics Announce Collaboration for CMT-SORD
…pursuit to develop treatments for the disease. https://www.cmtausa.org/understanding-cmt/what-is-cmt About the CMTA The CMTA is the largest philanthropic funder of CMT research worldwide. The CMTA’s Strategy to Accelerate Research (STAR) brings…
Family Planning For CMT – Part 2
…be a continued relationship of some kind with the biological parents (open or closed adoption). It is important for a family considering adoption to do the research and identify all…
Shift Pharmaceuticals, CMTA Partner on ASO Treatment for CMT1A
…Missouri, where Dr. Lorson performed the initial discovery and development. About CMTA The CMTA is the largest philanthropic funder of CMT research worldwide. The CMTA’s Strategy to Accelerate Research (STAR)…
A Retrospective Study of Subjects with Mutations in the C12ORF65 Gene Causing Complex CMT Type 6
…carries out specialist research into neurodegenerative diseases at the University of Cambridge and Addenbrooke’s Hospital. As a participant in this study, you would be asked to take part in a…
Pete Foley Joins CMTA Board of Directors
…nerves die, the muscles around them follow suit. All of the CMTA’s research efforts are consolidated under the banner of STAR—which brings together the world’s largest network of biotech research…
Gene Therapy Advances for CMT4J, CMT4A and GAN
…exploring additional CMT types that could benefit”. If you would like to support the CMTA’s research efforts, please make a donation in support of the CMTA’s Strategy to Accelerate Research….
The Adventures of Archy
…and she talked about “Archy” the mascot turtle of the association and how he has CMT. She explained that the point of the program was to raise money for research…
CMT Type 1
…not have a GJB1 gene). The sex of the parent or the child ONLY matters in X-linked inheritance. Research on CMT Type 1X Research for Demyelinating Forms of CMT ⟶…
Hereditary Sensory Neuropathy Serine trial (SENSE trial)
In December 2021, the Charcot-Marie-Tooth Association Strategy to Accelerate Research (CMTA-STAR) awarded Dr. Mary M. Reilly and her team at the UCL Queen Square Institute of Neurology in London $354,826…
CMTA Spring 2025 Report | EMPOWERING INDEPENDENCE: SMALL TOOLS, BIG IMPACT
…a big impact in improving daily life for people with CMT. This issue explores how assistive technology, innovative research, and a strong community are driving progress toward greater independence. From…